K+ channels as therapeutic drug targets

AD Wickenden - Pharmacology & therapeutics, 2002 - Elsevier
K+ channels play critical roles in a wide variety of physiological processes, including the
regulation of heart rate, muscle contraction, neurotransmitter release, neuronal excitability …

[图书][B] Handbook of clinical drug data

PO Anderson, JE Knoben - 2021 - repo.upertis.ac.id
The Tenth Edition of the Handbook of Clinical Drug Data continues a long tradition of
providing clinically relevant, well-referenced drug information compiled by expert clinicians …

A benefit-risk assessment of class III antiarrhythmic agents

B Brendorp, OD Pedersen, C Torp-Pedersen… - Drug safety, 2002 - Springer
With β-blockers as the exception, increasing doubt is emerging on the value of
antiarrhythmic drug therapy following a series of trials that have either shown no mortality …

Modeling atrial fibrillation using human embryonic stem cell-derived atrial tissue

Z Laksman, M Wauchop, E Lin, S Protze, J Lee… - Scientific reports, 2017 - nature.com
Since current experimental models of Atrial Fibrillation (AF) have significant limitations, we
used human embryonic stem cells (hESCs) to generate an atrial-specific tissue model of AF …

Combined pharmacological block of IKr and IKs increases short‐term QT interval variability and provokes torsades de pointes

C Lengyel, A Varró, K Tábori, JG Papp… - British journal of …, 2007 - Wiley Online Library
Background and purpose: Assessing the proarrhythmic potential of compounds during drug
development is essential. However, reliable prediction of drug‐induced torsades de pointes …

Adult human primary cardiomyocyte-based model for the simultaneous prediction of drug-induced inotropic and pro-arrhythmia risk

N Nguyen, W Nguyen, B Nguyenton… - Frontiers in …, 2017 - frontiersin.org
Cardiac safety remains the leading cause of drug development discontinuation. We
developed a human cardiomyocyte-based model that has the potential to provide a …

Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective …

B Houltz, B Darpö, N Edvardsson… - Pacing and clinical …, 1998 - Wiley Online Library
The aim of this study was to identify predictors of torsades de pointes (TdP) in patients with
atrial fibrillation (AF) or flutter exposed to the Class III antiarrhythmic drug almokalant. TdP …

Species plays an important role in drug‐induced prolongation of action potential duration and early afterdepolarizations in isolated Purkinje fibers

HR Lu, R Marien, ANN Saels… - Journal of …, 2001 - Wiley Online Library
Species and Drug‐Induced Long APD and EADs. Introduction: Although isolated Purkinje
fibers (PFs) often are used to evaluate the electrophysiologic effects of new drugs in terms of …

Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo …

BL Nørgaard, K Wachtell, PD Christensen… - American heart …, 1999 - Elsevier
Background This study was designed to assess the efficacy and safety of intravenous
dofetilide in acute termination of atrial fibrillation (AF) and flutter (AFL). Dofetilide, an …

Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257

C Thollon, JP Bidouard, C Cambarrat, L Lesage… - European journal of …, 1997 - Elsevier
The effects of the two isomers,(+)-S 16257 and (−)-S 16260, of a new bradycardic agent,(±)-
S 15544 (7, 8-dimethoxy 3-{3-{[(4, 5-dimethoxybenzocyclobutan-1-yl) methyl] methylamino} …